Total:606
S-1KK Combination Tablets T20（エスワンケーケー配合錠T20）
 |
|
| It is usually used for treatment of gastric cancer, colorectal cancer, head and neck cancer, non-small cell lung cancer, unresectable or recurrent breast cancer, pancreatic cancer, or biliary tract cancer. |
S-1KK Combination Tablets T25（エスワンケーケー配合錠T25）
 |
|
| It is usually used for treatment of gastric cancer, colorectal cancer, head and neck cancer, non-small cell lung cancer, unresectable or recurrent breast cancer, pancreatic cancer, or biliary tract cancer. |
S-1Meiji Combination Capsules T20（エスワンメイジ配合カプセルT20）
 |
|
| It is usually used to treat gastric cancer, colorectal cancer, head and neck cancer, non-small cell lung cancer, inoperable or recurrent breast cancer, pancreatic cancer and biliary cancer. |
S-1Meiji Combination Capsules T25（エスワンメイジ配合カプセルT25）
 |
|
| It is usually used to treat gastric cancer, colorectal cancer, head and neck cancer, non-small cell lung cancer, inoperable or recurrent breast cancer, pancreatic cancer and biliary cancer. |
S-1TAIHO combination OD tablets T20（エスワンタイホウ配合OD錠T20）
 |
|
| It is usually used to treat gastric cancer, colorectal cancer, head and neck cancer, non-small cell lung cancer, inoperable or recurrent breast cancer, pancreatic cancer, or biliary tract cancer. |
S-1TAIHO combination OD tablets T25（エスワンタイホウ配合OD錠T25）
 |
|
| It is usually used to treat gastric cancer, colorectal cancer, head and neck cancer, non-small cell lung cancer, inoperable or recurrent breast cancer, pancreatic cancer, or biliary tract cancer. |
SAHNE Ointment 0.5%（ザーネ軟膏0.5%）
 |
|
| It is usually used in the treatment of keratoderma. |
SALAGEN Granules 0.5%（サラジェン顆粒0.5%）
 |
|
| It is usually used to improve dry mouth symptoms associated with radiation therapy to the head and neck and in patients with Sjogren's syndrome. |
SALAGEN Tab. 5mg（サラジェン錠5mg）
 |
|
| It is usually used to improve dry mouth symptoms associated with radiation therapy to the head and neck and in patients with Sjogren's syndrome. |
SALAZAC COMBINATION GRANULES（サラザック配合顆粒）
 |
|
| It is usually used to improve or relieve nasal discharge/congestion, pharyngeal and laryngeal pain, headache, joint pain, muscle pain and fever associated with common cold or upper respiratory tract inflammation. |
SALAZOSULFAPYRIDINE Enteric Coated Tablets 250mg "CH"（サラゾスルファピリジン腸溶錠250mg「CH」）
 |
|
| It is usually used to treat rheumatoid arthritis. It may take 1 to 2 months for the medicine to be effective. |
SALAZOSULFAPYRIDINE Enteric Coated Tablets 500mg "CH"（サラゾスルファピリジン腸溶錠500mg「CH」）
 |
|
| It is usually used to treat rheumatoid arthritis. It may take 1 to 2 months for the medicine to be effective. |
SALAZOSULFAPYRIDINE Tablet 500mg "Nichiiko"（サラゾスルファピリジン錠500mg「日医工」）
 |
|
| It is usually used to treat ulcerative colitis, regional enteritis and nonspecific colitis. |
SALIPARA SOLUTION（サリパラ液）
 |
|
| It is usually used to treat cough and difficulty in expectoration accompanied with acute bronchitis, pneumonia and pulmonary tuberculosis. |
SALOBEL Tablets100mg（サロベール錠100mg）
 |
|
| It is usually used to treat gout or the symptom of hyperuricemia (in hypertension accompanied by hyperuricemia). |
SALOBEL Tablets50mg（サロベール錠50mg）
 |
|
| It is usually used to treat gout or the symptom of hyperuricemia (in hypertension accompanied by hyperuricemia). |
SALSOROITIN Injection 10mL（ザルソロイチン静注10mL）
 |
|
| It is usually used to treat symptomatic nerve pain and low back pain. |
SALSOROITIN Injection 20mL（ザルソロイチン静注20mL）
 |
|
| It is usually used to treat symptomatic nerve pain and low back pain. |
SAMSCA Granules 1% [Hyponatremia secondary to syndrome of inappropriate antidiuretic hormone secretion (SIADH)]（サムスカ顆粒1%［抗利尿ホルモン不適合分泌症候群（SIADH）における低ナトリウム血症］）
 |
|
| It is usually used to treat hyponatremia secondary to syndrome of inappropriate antidiuretic hormone secretion (SIADH). |
SAMSCA Granules 1% [Volume overload in heart failure and body fluid retention in hepatic cirrhosis]（サムスカ顆粒1%［心不全・肝硬変における体液貯留］）
 |
|
| It is usually used in combination with other diuretics when the other diuretics alone do not show sufficient effect. |
SAMSCA OD Tablets 15mg [Hyponatremia secondary to syndrome of inappropriate antidiuretic hormone secretion (SIADH)]（サムスカOD錠15mg［抗利尿ホルモン不適合分泌症候群（SIADH）における低ナトリウム血症］）
 |
|
| It is usually used to treat hyponatremia secondary to syndrome of inappropriate antidiuretic hormone secretion (SIADH). |
SAMSCA OD Tablets 15mg [Volume overload in heart failure]（サムスカOD錠15mg［心不全における体液貯留］）
 |
|
| It is usually used in combination with other diuretics when the other diuretics alone do not show sufficient effect. |
SAMSCA OD Tablets 30mg [Hyponatremia secondary to syndrome of inappropriate antidiuretic hormone secretion (SIADH)]（サムスカOD錠30mg［抗利尿ホルモン不適合分泌症候群（SIADH）における低ナトリウム血症］）
 |
|
| It is usually used to treat hyponatremia secondary to syndrome of inappropriate antidiuretic hormone secretion (SIADH). |
SAMSCA OD Tablets 7.5mg [Hyponatremia secondary to syndrome of inappropriate antidiuretic hormone secretion (SIADH)]（サムスカOD錠7.5mg［抗利尿ホルモン不適合分泌症候群（SIADH）における低ナトリウム血症］）
 |
|
| It is usually used to treat hyponatremia secondary to syndrome of inappropriate antidiuretic hormone secretion (SIADH). |
SAMSCA OD Tablets 7.5mg [Volume overload in heart failure and body fluid retention in hepatic cirrhosis]（サムスカOD錠7.5mg［心不全・肝硬変における体液貯留］）
 |
|
| It is usually used in combination with other diuretics when the other diuretics alone do not show sufficient effect. |
SAMSCA OD tablets 15mg [Autosomal dominant polycystic kidney disease]（サムスカOD錠15mg［常染色体優性多発性のう胞腎］）
 |
|
| It is usually used to slow the progression of rapidly enlarging autosomal dominant polycystic kidney disease in which the kidneys have already become enlarged. |
SAMSCA OD tablets 30mg [Autosomal dominant polycystic kidney disease]（サムスカOD錠30mg［常染色体優性多発性のう胞腎］）
 |
|
| It is usually used to slow the progression of rapidly enlarging autosomal dominant polycystic kidney disease in which the kidneys have already become enlarged. |
SAMSCA OD tablets 7.5mg [Autosomal dominant polycystic kidney disease]（サムスカOD錠7.5mg［常染色体優性多発性のう胞腎］）
 |
|
| It is usually used to slow the progression of rapidly enlarging autosomal dominant polycystic kidney disease in which the kidneys have already become enlarged. |
SAMSCA Tablets 15mg [Hyponatremia secondary to syndrome of inappropriate antidiuretic hormone secretion (SIADH)]（サムスカ錠15mg［抗利尿ホルモン不適合分泌症候群（SIADH）における低ナトリウム血症］）
 |
|
| It is usually used to treat hyponatremia secondary to syndrome of inappropriate antidiuretic hormone secretion (SIADH). |
SAMSCA Tablets 15mg [Volume overload in heart failure]（サムスカ錠15mg［心不全における体液貯留］）
 |
|
| It is usually used in combination with other diuretics when the other diuretics alone do not show sufficient effect. |
SAMSCA Tablets 30mg [Hyponatremia secondary to syndrome of inappropriate antidiuretic hormone secretion (SIADH)]（サムスカ錠30mg［抗利尿ホルモン不適合分泌症候群（SIADH）における低ナトリウム血症］）
 |
|
| It is usually used to treat hyponatremia secondary to syndrome of inappropriate antidiuretic hormone secretion (SIADH). |
SAMSCA Tablets 7.5mg [Hyponatremia secondary to syndrome of inappropriate antidiuretic hormone secretion (SIADH)]（サムスカ錠7.5mg［抗利尿ホルモン不適合分泌症候群（SIADH）における低ナトリウム血症］）
 |
|
| It is usually used to treat hyponatremia secondary to syndrome of inappropriate antidiuretic hormone secretion (SIADH). |
SAMSCA Tablets 7.5mg [Volume overload in heart failure and body fluid retention in hepatic cirrhosis]（サムスカ錠7.5mg［心不全・肝硬変における体液貯留］）
 |
|
| It is usually used in combination with other diuretics when the other diuretics alone do not show sufficient effect. |
SAMSCA granules 1% [Autosomal dominant polycystic kidney disease]（サムスカ顆粒1%［常染色体優性多発性のう胞腎］）
 |
|
| It is usually used to slow the progression of rapidly enlarging autosomal dominant polycystic kidney disease in which the kidneys have already become enlarged. |
SAMSCA tablets 15mg [Autosomal dominant polycystic kidney disease]（サムスカ錠15mg［常染色体優性多発性のう胞腎］）
 |
|
| It is usually used to slow the progression of rapidly enlarging autosomal dominant polycystic kidney disease in which the kidneys have already become enlarged. |
SAMSCA tablets 30mg [Autosomal dominant polycystic kidney disease]（サムスカ錠30mg［常染色体優性多発性のう胞腎］）
 |
|
| It is usually used to slow the progression of rapidly enlarging autosomal dominant polycystic kidney disease in which the kidneys have already become enlarged. |
SAMSCA tablets 7.5mg [Autosomal dominant polycystic kidney disease]（サムスカ錠7.5mg［常染色体優性多発性のう胞腎］）
 |
|
| It is usually used to slow the progression of rapidly enlarging autosomal dominant polycystic kidney disease in which the kidneys have already become enlarged. |
SAMTIREL Oral Suspension 15%（サムチレール内用懸濁液15％）
 |
|
| It is usually used to treat pneumocystis pneumonia and to suppress symptom onset. |
SARPOGRELATE HYDROCHLORIDE Tablets 100mg [SANWA]（サルポグレラート塩酸塩錠100mg「三和」）
 |
|
| It is usually used for treatment of ischemic symptoms including ulcer, pain and chilly sensation, associated with chronic arterial occlusion. |
SARPOGRELATE HYDROCHLORIDE Tablets 50mg [SANWA]（サルポグレラート塩酸塩錠50mg「三和」）
 |
|
| It is usually used for treatment of ischemic symptoms including ulcer, pain and chilly sensation, associated with chronic arterial occlusion. |
SARPOGRELATE HYDROCHLORIDE TABLETS 100mg "NP"（サルポグレラート塩酸塩錠100mg「NP」）
 |
|
| It is usually used to improve various ischemic symptoms such as ulcers/pain/cold feeling associated with chronic arterial occlusion. |
SARPOGRELATE HYDROCHLORIDE TABLETS 100mg "OHARA"（サルポグレラート塩酸塩錠100mg「オーハラ」）
 |
|
| It is usually used in the treatment of ulcer and improvement of the ischemic symptoms such as pain and coldness associated with chronic arterial obstruction. |
SARPOGRELATE HYDROCHLORIDE TABLETS 100mg "TOWA"（サルポグレラート塩酸塩錠100mg「トーワ」）
 |
|
| It is usually used to treat various ischemic symptoms such as ulcer, pain and feeling of coldness associated with chronic arterial occlusion. |
SARPOGRELATE HYDROCHLORIDE TABLETS 100mg "YD"（サルポグレラート塩酸塩錠100mg「YD」）
 |
|
| It is usually used to treatment ulcer associated with chronic arterial occlusion and ischemic symptoms. |
SARPOGRELATE HYDROCHLORIDE TABLETS 50mg "NP"（サルポグレラート塩酸塩錠50mg「NP」）
 |
|
| It is usually used to improve various ischemic symptoms such as ulcers/pain/cold feeling associated with chronic arterial occlusion. |
SARPOGRELATE HYDROCHLORIDE TABLETS 50mg "OHARA"（サルポグレラート塩酸塩錠50mg「オーハラ」）
 |
|
| It is usually used in the treatment of ulcer and improvement of the ischemic symptoms such as pain and coldness associated with chronic arterial obstruction. |
SARPOGRELATE HYDROCHLORIDE TABLETS 50mg "TOWA"（サルポグレラート塩酸塩錠50mg「トーワ」）
 |
|
| It is usually used to treat various ischemic symptoms such as ulcer, pain and feeling of coldness associated with chronic arterial occlusion. |
SARPOGRELATE HYDROCHLORIDE TABLETS 50mg "YD"（サルポグレラート塩酸塩錠50mg「YD」）
 |
|
| It is usually used to treat ulcer associated with chronic arterial occlusion and ischemic symptoms. |
SARPOGRELATE HYDROCHLORIDE Tablets 100 mg "MEEK"（サルポグレラート塩酸塩錠100mg「MEEK」）
 |
|
| It is usually used to improve ischemic symptoms including ulcer, associated with chronic arterial occlusion. |
SARPOGRELATE HYDROCHLORIDE Tablets 100mg "MEEK"（サルポグレラート塩酸塩錠100mg「MEEK」）
 |
|
| It is usually used to improve various ischemic symptoms such as ulcers/pain/cold feeling associated with chronic arterial occlusion. |
